X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMC 1736077)

Published in J Med Genet on June 01, 2005

Authors

D Pimenides, N D L George, J R W Yates, K Bradshaw, S A Roberts, A T Moore, D Trump

Articles citing this

X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Prog Retin Eye Res (2012) 1.66

X-linked retinoschisis: an update. J Med Genet (2006) 1.64

Novel phenotypic and genotypic findings in X-linked retinoschisis. Arch Ophthalmol (2007) 1.34

Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol (2006) 1.28

ERG variability in X-linked congenital retinoschisis patients with mutations in the RS1 gene and the diagnostic importance of fundus autofluorescence and OCT. Doc Ophthalmol (2007) 1.27

Clinical and genetic findings in Hungarian patients with X-linked juvenile retinoschisis. Mol Vis (2008) 1.18

Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene. Invest Ophthalmol Vis Sci (2011) 1.05

Clinical features of X linked juvenile retinoschisis in Chinese families associated with novel mutations in the RS1 gene. Mol Vis (2007) 1.04

Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis. Hum Mol Genet (2010) 1.00

Novel XLRS1 gene mutations cause X-linked juvenile retinoschisis in Chinese families. Jpn J Ophthalmol (2008) 0.95

Molecular genetic characteristics of X-linked retinoschisis in Koreans. Mol Vis (2009) 0.93

Clinical characteristics and current therapies for inherited retinal degenerations. Cold Spring Harb Perspect Med (2014) 0.92

Test-Retest Intervisit Variability of Functional and Structural Parameters in X-Linked Retinoschisis. Transl Vis Sci Technol (2014) 0.91

Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains. Mol Vis (2007) 0.90

Genetic modification of the schisis phenotype in a mouse model of X-linked retinoschisis. Genetics (2008) 0.88

Molecular modeling indicates distinct classes of missense variants with mild and severe XLRS phenotypes. Hum Mol Genet (2013) 0.87

Characterization of novel RS1 exonic deletions in juvenile X-linked retinoschisis. Mol Vis (2013) 0.84

Truncation of retinoschisin protein associated with a novel splice site mutation in the RS1 gene. Mol Vis (2008) 0.82

Circadian regulation of retinoschisin in the chick retina. Invest Ophthalmol Vis Sci (2008) 0.81

Tyrosinase is the modifier of retinoschisis in mice. Genetics (2010) 0.80

Novel mutations of the RS1 gene in a cohort of Chinese families with X-linked retinoschisis. Mol Vis (2014) 0.79

Biology of retinoschisin. Adv Exp Med Biol (2012) 0.77

A novel truncating Rs1 mutation associated with X-linked juvenile retinoschisis. Jpn J Ophthalmol (2007) 0.77

The X-linked juvenile retinoschisis protein retinoschisin is a novel regulator of mitogen-activated protein kinase signalling and apoptosis in the retina. J Cell Mol Med (2016) 0.75

Phenotypic characterization of X-linked retinoschisis: Clinical, electroretinography, and optical coherence tomography variables. Indian J Ophthalmol (2016) 0.75

Case report of an atypical early onset X-linked retinoschisis in monozygotic twins. BMC Ophthalmol (2017) 0.75

Articles by these authors

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med (1999) 6.21

Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol (1999) 4.12

The genetics of childhood cataract. J Med Genet (2000) 3.99

A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07

A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2012) 2.78

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67

Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus (2006) 2.60

The effect of chemical treatments of albumin and orosomucoid on rate of clearance from the rat bloodstream and rate of pinocytic capture of rat yolk sac cultured in vitro. Biochem J (1977) 2.36

X linked retinoschisis. Br J Ophthalmol (1995) 2.13

Resolution of peanut allergy: case-control study. BMJ (1998) 2.11

Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer. Clin Radiol (2012) 2.08

PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05

Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol (1998) 1.93

Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93

Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet (2008) 1.87

Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84

Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J (2001) 1.83

Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut (1992) 1.82

Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77

The cone dysfunction syndromes. Br J Ophthalmol (2004) 1.76

Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet (1996) 1.76

Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol (1996) 1.73

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod (2011) 1.72

Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71

Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops. Am J Epidemiol (2001) 1.71

Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70

Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics (1997) 1.70

Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertil Steril (1994) 1.69

A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract. J Med Genet (2006) 1.68

Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol (1991) 1.67

Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol (1999) 1.64

The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer (1997) 1.63

Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61

A locus for autosomal dominant posterior polar cataract on chromosome 1p. Hum Mol Genet (1997) 1.57

Lens biology: development and human cataractogenesis. Trends Genet (1999) 1.55

Age-related macular degeneration and the complement system. Immunobiology (2011) 1.52

Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med (2000) 1.52

Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. Br J Surg (2009) 1.52

The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol (1992) 1.51

A locus for autosomal dominant anterior polar cataract on chromosome 17p. Hum Mol Genet (1996) 1.51

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49

A prospective randomized study of pregnancy rates following intrauterine and intracervical insemination using frozen donor sperm. Fertil Steril (1990) 1.47

Genetic predisposition in breast cancer. Lancet (1994) 1.47

Nitric oxide binding to nitrophorin 4 induces complete distal pocket burial. Nat Struct Biol (2000) 1.46

Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet (2002) 1.44

Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. J Med Genet (2004) 1.44

Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet (2000) 1.43

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42

Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42

Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther (2007) 1.42

Molecular genetic analysis of the 3p- syndrome. Hum Mol Genet (1994) 1.40

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40

Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol (2000) 1.39

Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36

A Java-based multi-institutional medical information retrieval system. Proc AMIA Annu Fall Symp (1997) 1.36

A novel connexin50 mutation associated with congenital nuclear pulverulent cataracts. J Med Genet (2007) 1.35

Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Hum Reprod (2004) 1.34

Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet (1998) 1.33

Genetic counselling in X-linked ocular albinism: clinical features of the carrier state. Eye (Lond) (1992) 1.32

The role of nonrandomized trials in the evaluation of oncology drugs. Clin Pharmacol Ther (2015) 1.32

Histiocytosis X: an ophthalmological review. Br J Ophthalmol (1985) 1.30

Clinical features of affected males with X linked ocular albinism. Br J Ophthalmol (1993) 1.30

Cranial hemihypertrophy and neurodevelopmental prognosis. J Med Genet (1990) 1.29

Characterization of the G91del CRYBA1/3-crystallin protein: a cause of human inherited cataract. Hum Mol Genet (2004) 1.29

Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol (2006) 1.28

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer (2009) 1.27

Fibrous dysplasia of the orbit in childhood. Clinical features and management. Ophthalmology (1985) 1.26

The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol (1990) 1.26

Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone (2005) 1.25

X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet (2008) 1.24

The crypt cycle in mouse small intestinal epithelium. J Cell Sci (1994) 1.24

Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24

Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res (2001) 1.24

Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. Genomics (1998) 1.23

Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol (1990) 1.23

Genetic mapping in Methylophilus methylotrophus AS1. J Gen Microbiol (1983) 1.22

Preschool vision screening: outcome of children referred to the hospital eye service. Br J Ophthalmol (1996) 1.21

Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampus. Eur J Neurosci (2004) 1.21

Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer (1998) 1.21

Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer (1991) 1.21

Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab (1998) 1.20

Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase. Ophthalmology (2000) 1.20

Infantile presentation of X linked retinoschisis. Br J Ophthalmol (1995) 1.20

The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer (1988) 1.19

Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br J Cancer (1994) 1.19

The number of clonogenic cells in crypts in three regions of murine large intestine. Int J Radiat Biol (1997) 1.19

A randomized, controlled trial of vitamin D supplementation upon musculoskeletal health in postmenarchal females. J Clin Endocrinol Metab (2010) 1.18

Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet (2005) 1.18

Identification of the gene for Nance-Horan syndrome (NHS). J Med Genet (2004) 1.17

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol (1995) 1.16

Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye (Lond) (2005) 1.16

The clonogen content of murine intestinal crypts: dependence on radiation dose used in its determination. Radiat Res (1992) 1.15

The cone dystrophies. Eye (Lond) (1998) 1.15

Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer (2008) 1.15